---
input_text: 'Autoimmune movement disorders. Autoimmune movement disorders encapsulate
  a large and diverse group of neurologic disorders occurring either in isolation
  or accompanying more diffuse autoimmune encephalitic illnesses. The full range of
  movement phenomena has been described and, as they often occur in adults, many of
  the presentations can mimic neurodegenerative disorders, such as Huntington disease.
  Disorders may be ataxic, hypokinetic (parkinsonism), or hyperkinetic (myoclonus,
  chorea, tics, and other dyskinetic disorders). The autoantibody targets are diverse
  and include neuronal surface proteins such as leucine-rich, glioma-inactivated 1
  (LGI1) and glycine receptors, as well as antibodies (such as intracellular antigens)
  that are markers of a central nervous system process mediated by CD8+ cytotoxic
  T cells. However, there are two conditions, stiff-person syndrome (also known as
  stiff-man syndrome) and progressive encephalomyelitis with rigidity and myoclonus
  (PERM), that are always autoimmune movement disorders. In some instances (such as
  Purkinje cell cytoplasmic antibody-1 (PCA-1) autoimmunity), antibodies detected
  in serum and cerebrospinal fluid can be indicative of a paraneoplastic cause, and
  may direct the cancer search. In other instances (such as 65kDa isoform of glutamic
  acid decarboxylase (GAD65) autoimmunity), a paraneoplastic cause is very unlikely,
  and early treatment with immunotherapy may promote improvement or recovery. Here
  we describe the different types of movement disorder and the clinical features and
  antibodies associated with them, and discuss treatment. '
raw_completion_output: |-
  primary_disease: Autoimmune movement disorders

  medical_actions: immunotherapy

  symptoms: ataxia; hypokinetic (parkinsonism); hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders)

  chemicals: leucine-rich, glioma-inactivated 1 (LGI1); glycine receptors; Purkinje cell cytoplasmic antibody-1 (PCA-1); 65kDa isoform of glutamic acid decarboxylase (GAD65)

  action_annotation_relationships: immunotherapy TREATS ataxia IN Autoimmune movement disorders; immunotherapy TREATS hypokinetic (parkinsonism) IN Autoimmune movement disorders; immunotherapy TREATS hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders) IN Autoimmune movement disorders
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  immunotherapy TREATS hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders) IN Autoimmune movement disorders

  ===

extracted_object:
  primary_disease: Autoimmune movement disorders
  medical_actions:
    - immunotherapy
  symptoms:
    - HP:0001251
    - HP:0001300
    - hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders)
  chemicals:
    - leucine-rich, glioma-inactivated 1 (LGI1)
    - glycine receptors
    - Purkinje cell cytoplasmic antibody-1 (PCA-1)
    - 65kDa isoform of glutamic acid decarboxylase (GAD65)
  action_annotation_relationships:
    - subject: immunotherapy
      predicate: TREATS
      object: HP:0001251
      qualifier: Autoimmune movement disorders
    - subject: immunotherapy
      predicate: TREATS
      object: HP:0001300
      qualifier: Autoimmune movement disorders
    - subject: immunotherapy
      predicate: TREATS
      object: hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders)
      qualifier: Autoimmune movement disorders
      subject_extension: immunotherapy
named_entities:
  - id: MONDO:0005559
    label: Neurodegeneration
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0000708
    label: Behavioral changes
  - id: CHEBI:64645
    label: Beta-amyloid
  - id: CHEBI:36355
    label: Tau
  - id: MONDO:0002602
    label: Central Nervous System Diseases
  - id: HP:0000618
    label: Blindness
  - id: HP:0001658
    label: Myocardial infarction
  - id: MONDO:0007739
    label: Huntington disease
  - id: MAXO:0009017
    label: cognitive tests
  - id: HP:0001268
    label: cognitive decline
  - id: MONDO:0020074
    label: Progressive Myoclonic Epilepsy (PME)
  - id: MAXO:0000932
    label: Electroencephalography (EEG) studies
  - id: HP:0025464
    label: oxidative stress
  - id: CHEBI:16610
    label: Spermidine
  - id: CHEBI:16348
    label: 3-nitropropionic acid (3-NP)
  - id: CHEBI:16856
    label: Glutathione (GSH)
  - id: CHEBI:16301
    label: Nitrite
  - id: CHEBI:63895
    label: Interleukin (IL)-6
  - id: CHEBI:16865
    label: Gamma-aminobutyric acid (GABA)
  - id: CHEBI:29987
    label: Glutamate
  - id: CHEBI:17256
    label: Dopamine (DA)
  - id: CHEBI:33310
    label: Norepinephrine (NE)
  - id: CHEBI:28790
    label: 5-HT
  - id: CHEBI:41941
    label: 3,4-dihydroxyphenylacetic acid (DOPAC)
  - id: CHEBI:545959
    label: Homovanillic acid (HVA)
  - id: CHEBI:27823
    label: 5-hydroxyindoleacetic acid (5-HIAA)
  - id: CHEBI:16335
    label: Adenosine
  - id: CHEBI:17596
    label: Inosine
  - id: CHEBI:17368
    label: Hypoxanthine
  - id: HP:0003202
    label: muscle wasting
  - id: MAXO:0000127
    label: Genetic testing
  - id: MAXO:0000137
    label: PET scan
  - id: MONDO:0019260
    label: Adult Neuronal Ceroid Lipofuscinosis (ANCL)
  - id: CHEBI:53018
    label: dinitrophenol (DNP)
  - id: CHEBI:25675
    label: oligomycin
  - id: HP:0004305
    label: Involuntary movements
  - id: HP:0002072
    label: chorea
  - id: HP:0001824
    label: weight loss
  - id: CHEBI:27314
    label: water-soluble vitamins
  - id: CHEBI:46662
    label: minerals
  - id: MAXO:0000610
    label: Enzyme-linked immunosorbent assay
  - id: HP:0000739
    label: Anxiety
  - id: HP:0000716
    label: Depression
  - id: MONDO:0010997
    label: Progressive supranuclear palsy (PSP)
  - id: HP:0000605
    label: Supranuclear gaze palsy (SGP)
  - id: MONDO:0005180
    label: Parkinson disease
  - id: CHEBI:134738
    label: Laquinimod
  - id: HP:0012743
    label: abdominal obesity
  - id: CHEBI:28240
    label: Dichloroacetate
  - id: CHEBI:46024
    label: Trichostatin A
  - id: CHEBI:30513
    label: Sodium butyrate (SB)
  - id: CHEBI:75316
    label: Sodium phenylbutyrate
  - id: CHEBI:64103
    label: Sodium butyrate
  - id: CHEBI:51232
    label: Hoechst 33342
  - id: CHEBI:51240
    label: propidium iodide
  - id: CHEBI:30452
    label: TES
  - id: CHEBI:9754
    label: Tris
  - id: MAXO:0001351
    label: rehabilitation (occupational therapy)
  - id: CHEBI:16919
    label: creatine
  - id: MONDO:0005071
    label: Neurological Disorders
  - id: HP:0001288
    label: Abnormal gait
  - id: MONDO:0005301
    label: multiple sclerosis
  - id: MONDO:0009366
    label: normal pressure hydrocephalus
  - id: CHEBI:29237
    label: Deuterium
  - id: MAXO:0000427
    label: brain magnetic resonance imaging
  - id: HP:0003447
    label: axonal loss
  - id: HP:0033051
    label: Impaired executive functioning
  - id: MAXO:0000079
    label: Genetic counseling
  - id: CHEBI:38697
    label: Anthocyanins
  - id: CHEBI:15889
    label: Sterols
  - id: HP:0001251
    label: ataxia
  - id: HP:0001300
    label: hypokinetic (parkinsonism)
